ストックスクリーナーアプリを入手
30.65
3.13%
0.93
アフターアワーズ：
30.69
0.04
+0.13%
前日終値:
$29.72
開ける：
$29.65
24時間の取引高:
626.49K
Relative Volume:
0.77
時価総額：
$2.13B
収益：
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
+21.24%
1か月 パフォーマンス:
-4.64%
6か月 パフォーマンス:
+26.29%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$28.61
$31.46
1週間の範囲:
$25.27
$31.51
52週間の値動き範囲:
$18.84
$39.61
Alamar Biosciences Inc Stock (ALMR) Company Profile
Compare ALMR vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
30.65 | 2.13B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.19 | 117.83B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.67 | 66.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.04 | 51.32B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Stock (ALMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-05-12 | 開始されました | BofA Securities | Neutral |
| 2026-05-12 | 開始されました | JP Morgan | Overweight |
| 2026-05-12 | 開始されました | Leerink Partners | Outperform |
| 2026-05-12 | 開始されました | Stifel | Buy |
| 2026-05-12 | 開始されました | TD Cowen | Buy |
Alamar Biosciences Inc (ALMR) 最新ニュース
Form 4 Alamar Biosciences: Qiming Corporate GP VI, Ltd. (10% Owner) For: 19 October - Investing.com Canada
Four Qiming holders sold 173,673 Alamar Biosciences (ALMR) shares on October 15–16, 2026. - Stock Titan
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com Nigeria
Form 144 Alamar Biosciences For: 14 October By Investing.com - Investing.com UK
J.P. Morgan is broker for an affiliate’s proposed share sale at Alamar Biosciences (ALMR). - Stock Titan
An affiliate proposes selling 1.56M shares of Alamar Biosciences (Nasdaq: ALMR). - Stock Titan
An affiliate proposes selling 41,945 Alamar Biosciences (ALMR) shares through J.P. Morgan Securities LLC. - Stock Titan
Certain Class B Common Stock of Alamar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 14-OCT-2026. - www.marketscreener.com
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - The Manila Times
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - www.marketscreener.com
Alamar Biosciences Study in The Lancet Neurology Finds Distinct Biomarker Responses to Lecanemab in Early Alzheimer’s Disease - Quiver Quantitative
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment - GlobeNewswire Inc.
Why is Alamar Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Mistras Group, Strategy, Hyperliquid Strategies And Other Big Stocks Moving Higher On Friday - benzinga.com
Ragusa Robert P. Acquires 5,686 Shares and 25,599 Derivative Securities of Alamar Biosciences - Kalkine Media
Alamar Biosciences (ALMR) director has no reported share holdings - Stock Titan
Alamar Biosciences (ALMR) director gets new RSUs and stock option grant - Stock Titan
Alamar Biosciences Slides After Conference Hype Fades - TipRanks
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - manilatimes.net
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
Alamar Biosciences, Inc. Announces Appointment of Robert Ragusa as Director and Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, Effective September 1, 2026 - marketscreener.com
Alamar Biosciences expands proteomics partnership by 86,000 samples - Investing.com Nigeria
Valion Bio Announces Reverse Stock Split - Yahoo Finance
Alamar Biosciences Stock: Promising But Expensive Proteomics Growth (NASDAQ:ALMR) - Seeking Alpha
Alamar Stock: The Content Flywheel Is More Valuable Than The Instrument (ALMR) - Seeking Alpha
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure - Sahm
Alamar Biosciences (ALMR): Yuling Luo discloses 6.4% beneficial ownership stake - Stock Titan
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings ReportResults, Call & Slides - tipranks.com
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - kalkine.ca
Alamar Biosciences, Inc. Common Stock (NASDAQ: ALMR) Stock Price, News & Analysis - Kalkine
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - The Globe and Mail
Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM) - theglobeandmail.com
Alamar Biosciences Shares (ALMR) Surge 31% as Consumables Drive Gross Margin Up - TechStock²
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake - Stock Titan
Alamar Biosciences launches NULISAseq Immune 340 Panel for profiling - scanx.trade
Alamar Biosciences Q2 Results: Revenue Rises 82% To $29.4 Million - scanx.trade
Stifel raises Alamar Biosciences stock price target on earnings beat By Investing.com - Investing.com Canada
Alamar Biosciences Reports Q2 2026 Financial Results in Form 10-Q Filing - Kalkine Media
ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28 - Bitget
Alamar Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $33.4, Implies 19% Upside - TradingView
Alamar Biosciences, Inc. 2Q 2026: Revenue $29.4M, EPS $(0.22) — 10-Q Summary - TradingView
Stifel raises Alamar Biosciences stock price target on earnings beat - Investing.com
Big Sky Industrial Inc. Common Stock Q2 Earnings Call Highlights - Yahoo Finance
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Yahoo Finance Singapore
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Yahoo Finance
Alamar Biosciences to report Q2 2026 results on August 10, 2026 - scanx.trade
Form 8K Alamar Biosciences For: 10 August By Investing.com - Investing.com Nigeria
Alamar Biosciences Q2 Earnings Call Highlights - MarketBeat
Alamar Biosciences Inc (ALMR) 財務データ
Alamar Biosciences Inc (ALMR) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Alamar Biosciences Inc (ALMR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 19 '26 |
Sale |
26.34 |
75,508 |
1,988,881 |
180,808 |
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 16 '26 |
Sale |
27.02 |
136 |
3,675 |
182,128 |
| Qiming Corporate GP VI, Ltd. | 10% Owner |
Oct 15 '26 |
Sale |
27.73 |
173,537 |
4,812,446 |
182,130 |
| Qiming Managing Directors Fund | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.53 |
41,945 |
987,000 |
0 |
| Qiming Venture Partners VIII I | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
363,729 |
8,555,000 |
0 |
| Qiming Venture Partners VI, L. | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
1,558,858 |
36,664,000 |
0 |
| Qiming Venture Partners VIII-H | Affiliate |
Oct 14 '26 |
Proposed Sale |
23.52 |
435,468 |
10,242,000 |
0 |
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
| Illumina Innovation Fund II GP | 10% Owner |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
2.13%
3.76%
大文字化:
|
ボリューム (24 時間):